The astrocytoma drug market is estimated to be valued at USD 1.76 billion in 2025 and is expected to reach USD 3.10 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2032. https://penzu.com/p/1289174332372048